History of HPV in HPV-positive elderly women

History of HPV in HPV-positive elderly women

Background: The aim of this study was to examine the natural course of HPV infection in women of 60 years and older who were HPV positive at inclusion, and any association between HPV positivity in historical samples and dysplasia outcome. Methods: Eighty-nine women aged 60–82 years, who tested posi...

Full description

Bibliographic Details
Main Authors:	Ruth S. Hermansson, Gabriella Lillsunde-Larsson, Gisela Helenius, Mats G. Karlsson, Malin Kaliff, Matts Olovsson, Annika K. Lindström
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Subjects:	HPV Natural history Cervical dysplasia Women Elderly
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590161324000176

Similar Items

Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women
by: Ruth S. Hermansson, et al.
Published: (2022-08-01)

HPV prevalence and HPV-related dysplasia in elderly women.
by: Ruth S Hermansson, et al.
Published: (2018-01-01)

HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma
by: Gabriella Lillsunde Larsson, et al.
Published: (2018-12-01)

Older women’s perceptions of HPV self-sampling and HPV-sampling performed by a midwife – a phenomenographic study
by: Maria Hälleberg Nyman, et al.
Published: (2024-01-01)

Surgical Treatment for Early Cervical Cancer in the HPV Era: State of the Art
by: Mario Palumbo, et al.
Published: (2023-11-01)

Exploring the Bioactive Mycocompounds (Fungal Compounds) of Selected Medicinal Mushrooms and Their Potentials against HPV Infection and Associated Cancer in Humans
by: Tomas Rokos, et al.
Published: (2023-01-01)

An investigation into human papillomavirus (HPV) vaccination for patients undergoing surgery for high-grade cervical or vulvar dysplasia
by: Glenn P. Boyles, et al.
Published: (2022-06-01)

HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia
by: Malin Berggrund, et al.
Published: (2019-11-01)

The Impact of HPV Diagnosis and the Electrosurgical Excision Procedure (LEEP) on Mental Health and Sexual Functioning: A Systematic Review
by: Michalina Sikorska, et al.
Published: (2023-04-01)

Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution’s Experience
by: Marco Petrillo, et al.
Published: (2020-01-01)

Comprehensive treatment of cervical dysplasia from moderate to severe degree on the HPV infection background
by: Yu E Dobrohotova, et al.
Published: (2015-02-01)

Young Hungarian Students’ Knowledge about HPV and Their Attitude Toward HPV Vaccination
by: Bettina Claudia Balla, et al.
Published: (2016-12-01)

Significance of survivin immunoreactivity and morphometric analysis of HPV-induced cervical dysplasia
by: Vukomanović-Đurđević Biserka, et al.
Published: (2014-01-01)

Can Adjuvant HPV Vaccination Be Helpful in the Prevention of Persistent/Recurrent Cervical Dysplasia after Surgical Treatment?—A Literature Review
by: Kaja Michalczyk, et al.
Published: (2022-09-01)

Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis
by: Violante Di Donato, et al.
Published: (2021-04-01)

HPV-based screening for cervical cancer among women 55-59 years of age.
by: Lovisa Bergengren, et al.
Published: (2019-01-01)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022-05-01)

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
by: Ian N. Hampson
Published: (2022-04-01)

Updates on HPV Vaccination
by: Ojone Illah, et al.
Published: (2023-01-01)

The Distribution and Prevalence of High-Risk HPV Genotypes Other than HPV-16 and HPV-18 among Women Attending Gynecologists’ Offices in Kazakhstan
by: Gulzhanat Aimagambetova, et al.
Published: (2021-08-01)

Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.
by: Edward Kumakech, et al.
Published: (2016-01-01)

Knowledge of Human Papillomavirus (HPV) and the HPV Vaccine Among Medical and Nursing Students of Duhok, Iraq
by: Wahida A Ibrahim, et al.
Published: (2019-01-01)

Cervical, anal and oral HPV detection and HPV type concordance among women referred for colposcopy
by: Maria Nasioutziki, et al.
Published: (2020-04-01)

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations
by: Francisco I. Torres-Rojas, et al.
Published: (2021-06-01)

Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study
by: Riina Aarnio, et al.
Published: (2020-07-01)

Role of HPV16 E1 in cervical carcinogenesis
by: Fern Baedyananda, et al.
Published: (2022-07-01)

Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+
by: Malin Berggrund, et al.
Published: (2020-10-01)

A case of HPV-53-related cervical cancer in an elderly patient
by: Lieveld M, et al.
Published: (2014-11-01)

Knowledge, Attitudes and Behaviors of Medical School Students about HPV, HPV Vaccine and Cervical Cancer: A Survey Study in a Medical School
by: Ahmet Mert Ulucan, et al.
Published: (2022-12-01)

Multiple Human Papilloma Virus (HPV) Infections Are Associated with HSIL and Persistent HPV Infection Status in Korean Patients
by: Moonsik Kim, et al.
Published: (2021-07-01)

Knowledge and Awareness of Algerian Students about Cervical Cancer, HPV and HPV Vaccines: A Cross-Sectional Study
by: Djihad Bencherit, et al.
Published: (2022-08-01)

Gavi HPV Programs: Application to Implementation
by: Celina M. Hanson, et al.
Published: (2015-05-01)

Vaginal dysbiosis seems associated with hrHPV infection in women attending the Dutch Cervical Cancer Screening Program
by: Anne J. M. Loonen, et al.
Published: (2024-03-01)

Viral load, integration and methylation of E2BS3 and 4 in human papilloma virus (HPV) 16-positive vaginal and vulvar carcinomas.
by: Gabriella Lillsunde Larsson, et al.
Published: (2014-01-01)

Methods for screening and prevention of HPV infection – a retrospective study
by: Catalina Diana Stanica, et al.
Published: (2021-03-01)

Assessment of women's knowledge about HPV vaccination in the light of the HPV infection as a risk factor for cervical cancer
by: Arkadiusz Standyło, et al.
Published: (2020-09-01)

Oral HPV-associated dysplasia: is koilocytic dysplasia a separate entity?
by: Gabriela Anaya-Saavedra, et al.
Published: (2024-02-01)

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
by: Alice Avian, et al.
Published: (2022-05-01)

The impact of the HPV vaccine on the world
by: Daniel Vitorino Ribeiro, et al.
Published: (2020-12-01)

Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the HPV vaccine among parents of daughters in Riyadh, Saudi Arabia
by: Fatemah A. Alherz, et al.
Published: (2024-05-01)